agilon health, inc. (NYSE:AGL – Free Report) – Analysts at William Blair upped their Q3 2024 earnings estimates for agilon health in a research report issued on Tuesday, August 6th. William Blair analyst R. Daniels now anticipates that the company will post earnings of ($0.08) per share for the quarter, up from their prior estimate of ($0.10). The consensus estimate for agilon health’s current full-year earnings is ($0.34) per share. William Blair also issued estimates for agilon health’s Q4 2024 earnings at ($0.14) EPS, Q3 2025 earnings at ($0.05) EPS, Q4 2025 earnings at ($0.10) EPS and FY2025 earnings at ($0.11) EPS.
agilon health (NYSE:AGL – Get Free Report) last released its earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, meeting the consensus estimate of ($0.07). agilon health had a negative net margin of 5.67% and a negative return on equity of 26.15%. The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the firm earned ($0.04) earnings per share. The firm’s revenue for the quarter was up 38.7% compared to the same quarter last year.
View Our Latest Research Report on AGL
agilon health Stock Down 1.4 %
AGL stock opened at $5.52 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.33 and a quick ratio of 1.33. agilon health has a 1-year low of $4.41 and a 1-year high of $20.37. The firm has a fifty day moving average price of $6.51 and a two-hundred day moving average price of $5.99. The firm has a market cap of $2.27 billion, a price-to-earnings ratio of -7.89 and a beta of 0.60.
Institutional Investors Weigh In On agilon health
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Quest Partners LLC bought a new position in shares of agilon health during the fourth quarter valued at $45,000. Neo Ivy Capital Management acquired a new position in shares of agilon health during the 4th quarter worth about $47,000. J.Safra Asset Management Corp grew its position in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the period. Nomura Asset Management Co. Ltd. grew its position in shares of agilon health by 31.5% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 8,969 shares of the company’s stock valued at $113,000 after purchasing an additional 2,149 shares during the period. Finally, CWM LLC lifted its stake in agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after acquiring an additional 7,288 shares in the last quarter.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Stories
- Five stocks we like better than agilon health
- How to Effectively Use the MarketBeat Ratings Screener
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- MarketBeat Week in Review – 8/5 – 8/9
- How to Invest in Biotech Stocks
- The Cannabis Sector: Profitability Takes Center Stage
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.